Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans

scientific article

Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2008PNAS..10514585P
P356DOI10.1073/PNAS.0805048105
P932PMC publication ID2567192
P698PubMed publication ID18794525
P5875ResearchGate publication ID23258191

P50authorAnton Y. PelegQ42220362
Eleftherios MylonakisQ56769876
Beth Burgwyn FuchsQ63406367
P2093author name stringEmmanouil Tampakakis
Robert C Moellering
George M Eliopoulos
P2860cites workCommon Virulence Factors for Bacterial Pathogenicity in Plants and AnimalsQ28292772
Antifungal chemical compounds identified using a C. elegans pathogenicity assayQ28469125
An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutantsQ29614860
Nonfilamentous C. albicans mutants are avirulentQ29617839
Bacterial diversity within the human subgingival creviceQ30824037
Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungiQ30833128
Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1pQ33217380
NRG1, a repressor of filamentous growth in C.albicans, is down-regulated during filament inductionQ34077791
Geomicrobiology: how molecular-scale interactions underpin biogeochemical systems.Q34127929
Pseudomonas-Candida interactions: an ecological role for virulence factorsQ34134632
Regulatory roles of the GacS/GacA two-component system in plant-associated and other gram-negative bacteria.Q34478683
Acinetobacter baumannii: emergence of a successful pathogenQ34795807
New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesisQ35677298
Unveiling molecular scaffolds of the type IV secretion systemQ35695002
Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicansQ35783931
Developing animal models for polymicrobial diseasesQ35805388
Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infectionQ36370514
Isolation and characterization of an autoinducer synthase from Acinetobacter baumanniiQ36594556
Five-year review of infections in a burn intensive care unit: High incidence of Acinetobacter baumannii in a tropical climateQ36998159
Tyrosol is a quorum-sensing molecule in Candida albicansQ37416044
Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.Q39491534
Candida albicans biofilm-defective mutantsQ42975323
The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicansQ44120428
Attributable mortality of nosocomial candidemia, revisitedQ44386169
Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance SystemQ44727502
A bacterial cell-cell communication signal with cross-kingdom structural analoguesQ44734077
The antibacterial effects of terpene alcohols on Staphylococcus aureus and their mode of actionQ45024753
Integrative, multifunctional plasmids for hypha-specific or constitutive expression of green fluorescent protein in Candida albicansQ45035952
A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphologyQ45156903
Control of filament formation in Candida albicans by the transcriptional repressor TUP1.Q46154938
Suppression of hyphal formation in Candida albicans by mutation of a STE12 homologQ48077116
Device-associated nosocomial infections in 55 intensive care units of 8 developing countries.Q51118421
Evolution of species interactions in a biofilm communityQ59055799
Study of the antifungal activity of Acinetobacter baumannii LCH001 in vitro and identification of its antifungal componentsQ80396601
P433issue38
P407language of work or nameEnglishQ1860
P921main subjectCaenorhabditis elegansQ91703
P304page(s)14585-14590
P577publication date2008-09-15
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleProkaryote-eukaryote interactions identified by using Caenorhabditis elegans
P478volume105

Reverse relations

cites work (P2860)
Q92733350A New Front in Microbial Warfare-Delivery of Antifungal Effectors by the Type VI Secretion System
Q64060527A Novel Virulence Phenotype Rapidly Assesses Fungal Pathogenesis in Healthy and Immunocompromised Hosts
Q54384104A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway.
Q90350054A multimodel regime for evaluating effectiveness of antimicrobial wound care products in microbial biofilms
Q38008459Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models
Q35154057Alcohol enhances Acinetobacter baumannii-associated pneumonia and systemic dissemination by impairing neutrophil antimicrobial activity in a murine model of infection
Q38840796An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs
Q90589434Antibiofilm activities of ceragenins and antimicrobial peptides against fungal-bacterial mono and multispecies biofilms
Q46490376Binary Interactions of Antagonistic Bacteria with Candida albicans Under Aerobic and Anaerobic Conditions.
Q61448798Binding of Elementary Bodies by the Opportunistic Fungal Pathogen or Soluble β-Glucan, Laminarin, Inhibits Infectivity
Q35848074Biofilm models of polymicrobial infection
Q90295649Caenorhabditis elegans as a model animal for investigating fungal pathogenesis
Q89211305Caenorhabditis elegans in high-throughput screens for anti-infective compounds
Q37979713Caenorhabditis elegans, a model organism for investigating immunity
Q33864072Caenorhabditis elegans-based model systems for antifungal drug discovery
Q27317563Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis
Q42869350Candida albicans and Enterococcus faecalis in the gut: synergy in commensalism?
Q37410095Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model
Q40077323Candida and Pseudomonas interact to enhance virulence of mucosal infection in transparent zebrafish.
Q37942794Candida peritonitis: an update on the latest research and treatments
Q40746229Candida spp. airway colonization: A potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia
Q37648725Cellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicans
Q40910127Characteristics, Clinical Relevance, and the Role of Echinocandins in Fungal-Bacterial Interactions
Q34950943Characterization of genetic determinants that modulate Candida albicans filamentation in the presence of bacteria
Q28750198Characterization of mucosal Candida albicans biofilms
Q26996396Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity
Q35683105Competitive Interactions between C. albicans, C. glabrata and C. krusei during Biofilm Formation and Development of Experimental Candidiasis
Q37993409Complexity and dynamics of host-fungal interactions
Q37529923Cross-kingdom interactions: Candida albicans and bacteria
Q42074435Disarming Fungal Pathogens: Bacillus safensis Inhibits Virulence Factor Production and Biofilm Formation by Cryptococcus neoformans and Candida albicans.
Q28085214Dressed to impress: impact of environmental adaptation on the Candida albicans cell wall
Q46807780Dual-species relations between Candida tropicalis isolated from apple juice ultrafiltration membranes, with Escherichia coli O157:H7 and Salmonella sp.
Q28475908Duckweed (Lemna minor) as a model plant system for the study of human microbial pathogenesis
Q54293419Effects of sequential infections of Caenorhabditis elegans with Staphylococcus aureus and Proteus mirabilis.
Q34463258Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans
Q41031797Epidemiology of Methicillin-Resistant Staphylococcus aureus Bloodstream Coinfection Among Adults With Candidemia in Atlanta, GA, 2008-2012.
Q38005495Exploring the applications of invertebrate host-pathogen models for in vivo biofilm infections
Q35738043Fungal-bacterial interactions and their relevance in health
Q42025783Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics
Q41445306Genetic Dissection of the Type VI Secretion System in Acinetobacter and Identification of a Novel Peptidoglycan Hydrolase, TagX, Required for Its Biogenesis.
Q39063044Genetic Regulation of Virulence and Antibiotic Resistance in Acinetobacter baumannii
Q37301677Genetic diversity and multihost pathogenicity of clinical and environmental strains of Burkholderia cenocepacia
Q34985477Growth inhibition and excessive branching in Aphanomyces cochlioides induced by 2,4-diacetylphloroglucinol is linked to disruption of filamentous actin cytoskeleton in the hyphae.
Q38013796Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection
Q37832449IL-22 in antifungal immunity
Q36439189Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology
Q37907310Implications of interspecies signaling for virulence of bacterial and fungal pathogens.
Q35076900Insect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans model
Q26822968Insights into Acinetobacter baumannii pathogenicity
Q37190996Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium
Q38752373Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota
Q35080883Killing of Candida albicans filaments by Salmonella enterica serovar Typhimurium is mediated by sopB effectors, parts of a type III secretion system
Q38192498Mechanisms of synergy in polymicrobial infections
Q37720396Medically important bacterial-fungal interactions
Q39187216Microbe-mediated host defence drives the evolution of reduced pathogen virulence
Q34541225Microbial communities of the upper respiratory tract and otitis media in children
Q33626876Microbial interactions and differential protein expression in Staphylococcus aureus -Candida albicans dual-species biofilms
Q35867270Mitochondrial sorting and assembly machinery subunit Sam37 in Candida albicans: insight into the roles of mitochondria in fitness, cell wall integrity, and virulence
Q34189952Modulation of morphogenesis in Candida albicans by various small molecules
Q38679502Mouse model of colonization of the digestive tract with Acinetobacter baumannii and subsequent pneumonia
Q55266532Multidrug resistant pathogens respond differently to the presence of co-pathogen, commensal, probiotic and host cells.
Q26799027Noisy neighbourhoods: quorum sensing in fungal-polymicrobial infections
Q34067285Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates
Q38103941Pneumonia pathogen detection and microbial interactions in polymicrobial episodes
Q38963858Polymicrobial infections involving clinically relevant Gram-negative bacteria and fungi.
Q64074495Pseudomonas aeruginosa inhibits Rhizopus microsporus germination through sequestration of free environmental iron
Q37268119Rapid evolution of microbe-mediated protection against pathogens in a worm host
Q39991867Regulation of Acinetobacter baumannii biofilm formation
Q34184581Repertoire of intensive care unit pneumonia microbiota
Q36584408Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections
Q40224876Role of extracellular polymeric substances in polymicrobial biofilm infections of Staphylococcus epidermidis and Candida albicans modelled in the nematode Caenorhabditis elegans
Q61806012Signal Transduction Proteins in : Role in Antibiotic Resistance, Virulence, and Potential as Drug Targets
Q39846954The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells
Q54215616The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.
Q92404420The Mechanisms of Disease Caused by Acinetobacter baumannii
Q50001924The Microbial Zoo in the C. elegans Intestine: Bacteria, Fungi and Viruses
Q90113750The Pathobiome in Animal and Plant Diseases
Q98771335The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris
Q34229719The functions of Mediator in Candida albicans support a role in shaping species-specific gene expression
Q43077801The influence of bacterial interaction on the virulence of Cryptococcus neoformans
Q58723255Tipping the Balance: Adaptation in Polymicrobial Environments
Q64059475Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens
Q33936475Using C. elegans for antimicrobial drug discovery
Q26830123pH signaling in human fungal pathogens: a new target for antifungal strategies

Search more.